Position in ABEO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,415,252
+$1,462,095 QoQ
Shares Held
552,630
+26.8% QoQ
Ownership
0.966%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 125 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in ABEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. ABEO ranks #193 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ABEO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,415,252 | 552,630 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $1,953,157 | 435,973 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,209,867 | 419,330 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,229,357 | 422,227 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,466,379 | 434,222 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $860,702 | 180,820 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,030,054 | 184,929 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,096,209 | 173,451 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $735,850 | 173,550 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $933,082 | 128,701 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $660,933 | 131,923 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $457,403 | 108,647 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $416,037 | 103,235 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $95,022 | 33,696 | Shares | Defined | 2023-05-15 | |
| 2022-06-30 | $38,502 | 183,345 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $58,670 | 183,345 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $62,745 | 184,545 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $246,583 | 220,164 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $214,259 | 137,346 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,179,092 | 627,177 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,083,415 | 690,074 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $708,146 | 694,262 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,107,573 | 721,772 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $1,337,300 | 636,810 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||